inappropriate schedule of vaccine administered; Ill feeling after second dose; cold after second dose; dry cough after second dose; thumb pain after second dose; Throat swelling after second dose; Stiff neck after second dose; couldn't sleep after second dose; Felt agitated after second dose; Lymph nodes in groin tender after 2nd dose; knee pain after second dose; sore arm after second dose; joint pain after second dose; headache after second dose; feverish after second dose; chills after second dose; This spontaneous case was reported by a patient and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (inappropriate schedule of vaccine administered), MALAISE (Ill feeling after second dose), NASOPHARYNGITIS (cold after second dose), COUGH (dry cough after second dose) and PAIN IN EXTREMITY (thumb pain after second dose) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007m21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Arthritis. Concomitant products included IBUPROFEN for Arthritis, METFORMIN and LISINOPRIL for an unknown indication.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (inappropriate schedule of vaccine administered), MALAISE (Ill feeling after second dose), NASOPHARYNGITIS (cold after second dose), COUGH (dry cough after second dose), PAIN IN EXTREMITY (thumb pain after second dose), PHARYNGEAL SWELLING (Throat swelling after second dose), MUSCULOSKELETAL STIFFNESS (Stiff neck after second dose), INSOMNIA (couldn't sleep after second dose), AGITATION (Felt agitated after second dose), LYMPHADENOPATHY (Lymph nodes in groin tender after 2nd dose), ARTHRALGIA (knee pain after second dose), MYALGIA (sore arm after second dose), ARTHRALGIA (joint pain after second dose), HEADACHE (headache after second dose), PYREXIA (feverish after second dose) and CHILLS (chills after second dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (inappropriate schedule of vaccine administered) had resolved and MALAISE (Ill feeling after second dose), NASOPHARYNGITIS (cold after second dose), COUGH (dry cough after second dose), PAIN IN EXTREMITY (thumb pain after second dose), PHARYNGEAL SWELLING (Throat swelling after second dose), MUSCULOSKELETAL STIFFNESS (Stiff neck after second dose), INSOMNIA (couldn't sleep after second dose), AGITATION (Felt agitated after second dose), LYMPHADENOPATHY (Lymph nodes in groin tender after 2nd dose), ARTHRALGIA (knee pain after second dose), MYALGIA (sore arm after second dose), ARTHRALGIA (joint pain after second dose), HEADACHE (headache after second dose), PYREXIA (feverish after second dose) and CHILLS (chills after second dose) outcome was unknown.            Treatment details not included.The patient received both scheduled doses of mRNA 1273 before the events, therefore Action taken with mRNA-1273 in response to the events was not applicable   This case was linked to US-MODERNATX, INC.-MOD-2021-073168 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-073168:first dose